Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001367644-15-000019
Filing Date
2015-03-09
Accepted
2015-03-09 09:42:05
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 12/31/2014 10K/A form10k_a.htm 10-K/A 67848
2 EXHIBIT 31.3 exhibit31-3.htm EX-31.3 3249
3 EXHIBIT 31.4 exhibit31-4.htm EX-31.4 3232
10 image00001.jpg GRAPHIC 35187
  Complete submission text file 0001367644-15-000019.txt   11905095

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ebs-20141231.xml EX-101.INS 2105461
5 XBRL TAXONOMY EXTENSION SCHEMA ebs-20141231.xsd EX-101.SCH 65522
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20141231_cal.xml EX-101.CAL 102726
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20141231_def.xml EX-101.DEF 364004
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20141231_lab.xml EX-101.LAB 1049450
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20141231_pre.xml EX-101.PRE 619138
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33137 | Film No.: 15683807
SIC: 2834 Pharmaceutical Preparations